reviously generated against the S protein of SARS-CoV-1 was assessed.

Methods
The SARS-CoV-2 S protein sequence was aligned to those of SARS-CoV-1, Middle East respiratory syndrome (MERS) and common-cold coronaviruses. Abilities of mAbs generated